RCK specializes in the research and development of cannabis genetics, focusing on breeding and manufacturing elite hybrid seed varieties. The company has made significant advancements in decoding the genetics of cannabis plants, allowing for precise control over their chemical components. Utilizing a non-GMO, science-based approach, RCK has developed innovative technologies that facilitate the creation of new strains and stable hybrid seeds that meet rigorous medical standards. Their offerings are designed to cater to a wide range of medical and commercial applications, ensuring high-quality products for various needs.

The company's research and development efforts integrate traditional breeding techniques with advanced scientific methodologies. RCK employs next-generation sequencing, DNA analysis, and metabolomics-assisted selection, alongside marker-assisted breeding technologies, to enhance their breeding processes. This comprehensive approach not only supports the development of unique cannabis strains but also positions RCK as a leader in the cannabis industry, paving the way for a new era in cannabis cultivation that addresses diverse medical conditions.

Israel

RCK is an Israeli cannabis company, breeding repeatable & stable cannabis hybrid-seeds, for both medical & recreational markets.

RCK

Company Details